Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...
Implantable Infusion Pump MarketThe global implantable infusion pump market is set to witness significant growth, with an expected valuation of approximately USD 485.1 million in 2022. The market is ...
RBC expects 51% gross margins in 2024, with the Mobi pump launch driving long-term profitability. RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. TNDM, a global insulin ...
These factors are anticipated to contribute to an increase in new patient starts and insulin pump renewals. The firm also projects that Tandem Diabetes Care's stock could experience an expansion in ...